Replies to post #11290 on Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

You NEVER abandon a compound that can add value to the buy out. It simply does not work. It reveals a lot about their skill set. As they now are forced to move forward creating a salesforce, I’m worried as they will have just one drug to sell for at least the next 7 years. Share count will now explode..

[Ganz]

I hear ya Slim, the call was extremely informative.they want to put AUDREY on hold and focus on the LN rollout which creates more revenue and focus.They also eluded , on at least two occasions that they were really excited about their earnings report next week (the 12th).With the rollout only 2 months away and a strong earnings report, I look at this as an extremely good buying level, let’s face it, we all know this stock will at least double, and that’s the worst case scenario.